Global GM1 Gangliosidosis Treatment Market Growth (Status and Outlook) 2023-2029

March 2023 | 60 pages | ID: GF9F4035B511EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

GM1 Gangliosidosis is an inherited central nervous system disorder that destroys nerve cells in the spinal cord and brain.

LPI (LP Information)' newest research report, the “GM1 Gangliosidosis Treatment Industry Forecast” looks at past sales and reviews total world GM1 Gangliosidosis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected GM1 Gangliosidosis Treatment sales for 2023 through 2029. With GM1 Gangliosidosis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GM1 Gangliosidosis Treatment industry.

This Insight Report provides a comprehensive analysis of the global GM1 Gangliosidosis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GM1 Gangliosidosis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GM1 Gangliosidosis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GM1 Gangliosidosis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GM1 Gangliosidosis Treatment.

The global GM1 Gangliosidosis Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for GM1 Gangliosidosis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for GM1 Gangliosidosis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for GM1 Gangliosidosis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key GM1 Gangliosidosis Treatment players cover Axovant Gene Therapies Ltd and Passage Bio and Lysogene etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of GM1 Gangliosidosis Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• LYS-GM101
• PBGM01
• AXO-AAV-GM1

Segmentation by application

• Type 1 GM1 Gangliosidosis
• Type 2 GM1 Gangliosidosis
• Type 3 GM1 Gangliosidosis

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Axovant Gene Therapies Ltd
• Passage Bio and Lysogene

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global GM1 Gangliosidosis Treatment Market Size 2018-2029
  2.1.2 GM1 Gangliosidosis Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 GM1 Gangliosidosis Treatment Segment by Type
  2.2.1 LYS-GM101
  2.2.2 PBGM01
  2.2.3 AXO-AAV-GM1
2.3 GM1 Gangliosidosis Treatment Market Size by Type
  2.3.1 GM1 Gangliosidosis Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global GM1 Gangliosidosis Treatment Market Size Market Share by Type (2018-2023)
2.4 GM1 Gangliosidosis Treatment Segment by Application
  2.4.1 Type 1 GM1 Gangliosidosis
  2.4.2 Type 2 GM1 Gangliosidosis
  2.4.3 Type 3 GM1 Gangliosidosis
2.5 GM1 Gangliosidosis Treatment Market Size by Application
  2.5.1 GM1 Gangliosidosis Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global GM1 Gangliosidosis Treatment Market Size Market Share by Application (2018-2023)

3 GM1 GANGLIOSIDOSIS TREATMENT MARKET SIZE BY PLAYER

3.1 GM1 Gangliosidosis Treatment Market Size Market Share by Players
  3.1.1 Global GM1 Gangliosidosis Treatment Revenue by Players (2018-2023)
  3.1.2 Global GM1 Gangliosidosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global GM1 Gangliosidosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GM1 GANGLIOSIDOSIS TREATMENT BY REGIONS

4.1 GM1 Gangliosidosis Treatment Market Size by Regions (2018-2023)
4.2 Americas GM1 Gangliosidosis Treatment Market Size Growth (2018-2023)
4.3 APAC GM1 Gangliosidosis Treatment Market Size Growth (2018-2023)
4.4 Europe GM1 Gangliosidosis Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa GM1 Gangliosidosis Treatment Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas GM1 Gangliosidosis Treatment Market Size by Country (2018-2023)
5.2 Americas GM1 Gangliosidosis Treatment Market Size by Type (2018-2023)
5.3 Americas GM1 Gangliosidosis Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC GM1 Gangliosidosis Treatment Market Size by Region (2018-2023)
6.2 APAC GM1 Gangliosidosis Treatment Market Size by Type (2018-2023)
6.3 APAC GM1 Gangliosidosis Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe GM1 Gangliosidosis Treatment by Country (2018-2023)
7.2 Europe GM1 Gangliosidosis Treatment Market Size by Type (2018-2023)
7.3 Europe GM1 Gangliosidosis Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa GM1 Gangliosidosis Treatment by Region (2018-2023)
8.2 Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GM1 GANGLIOSIDOSIS TREATMENT MARKET FORECAST

10.1 Global GM1 Gangliosidosis Treatment Forecast by Regions (2024-2029)
  10.1.1 Global GM1 Gangliosidosis Treatment Forecast by Regions (2024-2029)
  10.1.2 Americas GM1 Gangliosidosis Treatment Forecast
  10.1.3 APAC GM1 Gangliosidosis Treatment Forecast
  10.1.4 Europe GM1 Gangliosidosis Treatment Forecast
  10.1.5 Middle East & Africa GM1 Gangliosidosis Treatment Forecast
10.2 Americas GM1 Gangliosidosis Treatment Forecast by Country (2024-2029)
  10.2.1 United States GM1 Gangliosidosis Treatment Market Forecast
  10.2.2 Canada GM1 Gangliosidosis Treatment Market Forecast
  10.2.3 Mexico GM1 Gangliosidosis Treatment Market Forecast
  10.2.4 Brazil GM1 Gangliosidosis Treatment Market Forecast
10.3 APAC GM1 Gangliosidosis Treatment Forecast by Region (2024-2029)
  10.3.1 China GM1 Gangliosidosis Treatment Market Forecast
  10.3.2 Japan GM1 Gangliosidosis Treatment Market Forecast
  10.3.3 Korea GM1 Gangliosidosis Treatment Market Forecast
  10.3.4 Southeast Asia GM1 Gangliosidosis Treatment Market Forecast
  10.3.5 India GM1 Gangliosidosis Treatment Market Forecast
  10.3.6 Australia GM1 Gangliosidosis Treatment Market Forecast
10.4 Europe GM1 Gangliosidosis Treatment Forecast by Country (2024-2029)
  10.4.1 Germany GM1 Gangliosidosis Treatment Market Forecast
  10.4.2 France GM1 Gangliosidosis Treatment Market Forecast
  10.4.3 UK GM1 Gangliosidosis Treatment Market Forecast
  10.4.4 Italy GM1 Gangliosidosis Treatment Market Forecast
  10.4.5 Russia GM1 Gangliosidosis Treatment Market Forecast
10.5 Middle East & Africa GM1 Gangliosidosis Treatment Forecast by Region (2024-2029)
  10.5.1 Egypt GM1 Gangliosidosis Treatment Market Forecast
  10.5.2 South Africa GM1 Gangliosidosis Treatment Market Forecast
  10.5.3 Israel GM1 Gangliosidosis Treatment Market Forecast
  10.5.4 Turkey GM1 Gangliosidosis Treatment Market Forecast
  10.5.5 GCC Countries GM1 Gangliosidosis Treatment Market Forecast
10.6 Global GM1 Gangliosidosis Treatment Forecast by Type (2024-2029)
10.7 Global GM1 Gangliosidosis Treatment Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Axovant Gene Therapies Ltd
  11.1.1 Axovant Gene Therapies Ltd Company Information
  11.1.2 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product Offered
  11.1.3 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Axovant Gene Therapies Ltd Main Business Overview
  11.1.5 Axovant Gene Therapies Ltd Latest Developments
11.2 Passage Bio and Lysogene
  11.2.1 Passage Bio and Lysogene Company Information
  11.2.2 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product Offered
  11.2.3 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Passage Bio and Lysogene Main Business Overview
  11.2.5 Passage Bio and Lysogene Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. GM1 Gangliosidosis Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of LYS-GM101
Table 3. Major Players of PBGM01
Table 4. Major Players of AXO-AAV-GM1
Table 5. GM1 Gangliosidosis Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global GM1 Gangliosidosis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global GM1 Gangliosidosis Treatment Market Size Market Share by Type (2018-2023)
Table 8. GM1 Gangliosidosis Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global GM1 Gangliosidosis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global GM1 Gangliosidosis Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global GM1 Gangliosidosis Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global GM1 Gangliosidosis Treatment Revenue Market Share by Player (2018-2023)
Table 13. GM1 Gangliosidosis Treatment Key Players Head office and Products Offered
Table 14. GM1 Gangliosidosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global GM1 Gangliosidosis Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global GM1 Gangliosidosis Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global GM1 Gangliosidosis Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global GM1 Gangliosidosis Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas GM1 Gangliosidosis Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas GM1 Gangliosidosis Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas GM1 Gangliosidosis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas GM1 Gangliosidosis Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas GM1 Gangliosidosis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas GM1 Gangliosidosis Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC GM1 Gangliosidosis Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC GM1 Gangliosidosis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC GM1 Gangliosidosis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe GM1 Gangliosidosis Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe GM1 Gangliosidosis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe GM1 Gangliosidosis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of GM1 Gangliosidosis Treatment
Table 46. Key Market Challenges & Risks of GM1 Gangliosidosis Treatment
Table 47. Key Industry Trends of GM1 Gangliosidosis Treatment
Table 48. Global GM1 Gangliosidosis Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global GM1 Gangliosidosis Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global GM1 Gangliosidosis Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global GM1 Gangliosidosis Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Axovant Gene Therapies Ltd Details, Company Type, GM1 Gangliosidosis Treatment Area Served and Its Competitors
Table 53. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product Offered
Table 54. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Axovant Gene Therapies Ltd Main Business
Table 56. Axovant Gene Therapies Ltd Latest Developments
Table 57. Passage Bio and Lysogene Details, Company Type, GM1 Gangliosidosis Treatment Area Served and Its Competitors
Table 58. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product Offered
Table 59. Passage Bio and Lysogene Main Business
Table 60. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Passage Bio and Lysogene Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. GM1 Gangliosidosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global GM1 Gangliosidosis Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. GM1 Gangliosidosis Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. GM1 Gangliosidosis Treatment Sales Market Share by Country/Region (2022)
Figure 8. GM1 Gangliosidosis Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global GM1 Gangliosidosis Treatment Market Size Market Share by Type in 2022
Figure 10. GM1 Gangliosidosis Treatment in Type 1 GM1 Gangliosidosis
Figure 11. Global GM1 Gangliosidosis Treatment Market: Type 1 GM1 Gangliosidosis (2018-2023) & ($ Millions)
Figure 12. GM1 Gangliosidosis Treatment in Type 2 GM1 Gangliosidosis
Figure 13. Global GM1 Gangliosidosis Treatment Market: Type 2 GM1 Gangliosidosis (2018-2023) & ($ Millions)
Figure 14. GM1 Gangliosidosis Treatment in Type 3 GM1 Gangliosidosis
Figure 15. Global GM1 Gangliosidosis Treatment Market: Type 3 GM1 Gangliosidosis (2018-2023) & ($ Millions)
Figure 16. Global GM1 Gangliosidosis Treatment Market Size Market Share by Application in 2022
Figure 17. Global GM1 Gangliosidosis Treatment Revenue Market Share by Player in 2022
Figure 18. Global GM1 Gangliosidosis Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas GM1 Gangliosidosis Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC GM1 Gangliosidosis Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe GM1 Gangliosidosis Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa GM1 Gangliosidosis Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas GM1 Gangliosidosis Treatment Value Market Share by Country in 2022
Figure 24. United States GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Region in 2022
Figure 29. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Type in 2022
Figure 30. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Application in 2022
Figure 31. China GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Country in 2022
Figure 38. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country GM1 Gangliosidosis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries GM1 Gangliosidosis Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global GM1 Gangliosidosis Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global GM1 Gangliosidosis Treatment Market Size Market Share Forecast by Application (2024-2029)